Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mardi, novembre 17
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Dogwood Therapeutics Inc
DWTX
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$1.08
0.02
1.89%
À la clôture: Nov 17, 4:00 PM EST
$1.10
0.02
1.85%
Après les heures: 9:28 AM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Comparer
Rapport sur les stocks
Dogwood Therapeutics Financials
Dogwood Therapeutics (DWTX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Dogwood Therapeutics Q3 EPS $(0.14) Beats $(0.15) Estimate, Sales $100.000K
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 98.29 percent increase over losses of $(8.20) per share
Benzinga Newsdesk
PRO
Dogwood Therapeutics Q2 EPS $(0.34) Misses $(0.14) Estimate
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.14) by 142.86 percent. This is a 82.91 percent increase over losses of $(1.99) per
Benzinga Newsdesk
PRO
Dogwood Therapeutics Q1 EPS $(0.15), Inline
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 98.22 percent increase over losses of $(8.45) per share from the same period last
Benzinga Newsdesk
Earnings Scheduled For May 14, 2026
Benzinga Insights
PRO
Dogwood Therapeutics Q4 EPS $(0.26) Beats $(1.17) Estimate
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(1.17) by 77.83 percent. This is a 95.87 percent increase over losses of $(6.29) per share
Benzinga Newsdesk
PRO
Dogwood Therapeutics Q3 EPS $(8.20) Misses $(1.58) Estimate
Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(8.20) per share which missed the analyst consensus estimate of $(1.58) by 418 percent. This is a 300 percent decrease over losses of $(2.05) per share
Benzinga Newsdesk